3-Amino-2-bromo-5-chloropyridine, 98.0%, 10g

2-Bromothiophene-3-carbonitrile, 97%, 5g

4-ethoxy-N-(furan-2-ylmethyl)benzo[d]thiazol-2-amine, 95.0%, 250mg

3-Methyl-4-(phenylsulfonamido)benzoic acid, 95%, 1g

5-Fluoro-2-iodonitrobenzene, 98.0%, 1g

1-Oxa-6-azaspiro[2,5]octane-6-carboxylic acid tert-butyl ester, 95.0%, 25g

N-(4,6-Dimethylpyrimidin-2-yl)benzene-1,4-diamine, 95.0%, 1g

3-(1-Oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-2-yl)piperidine-2,6-dione, 98%, 1g

Ethyl 2-(difluoromethyl)nicotinate, 97%, 50mg

2-(Difluoromethoxy)phenol, 95.0%, 5g

Azoture de sodium, min 98 %, pour synthèse, 2,5 kg, emballage plastique.

Ethyl 2-(((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)amino)-2-oxoacetate (Edoxaban Impurity), 97%, 50mg

1-Chloro-3-(4-chlorophenoxy)benzene, 95.0%, 100g